0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Cardiovascular medicine

Buy Now

The Evaluation of Beat Blocker and Calcium Antagonist Drugs (Paperback, Softcover reprint of the original 1st ed. 1982) Loot Price: R1,598
Discovery Miles 15 980
The Evaluation of Beat Blocker and Calcium Antagonist Drugs (Paperback, Softcover reprint of the original 1st ed. 1982): J....

The Evaluation of Beat Blocker and Calcium Antagonist Drugs (Paperback, Softcover reprint of the original 1st ed. 1982)

J. Morganroth, E.Neil Moore

Series: Developments in Cardiovascular Medicine, 18

 (sign in to rate)
Loot Price R1,598 Discovery Miles 15 980 | Repayment Terms: R150 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

With the beginning of the 1980's it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring medical therapy for hypertension, angina pectoris, arrhythmias, congestive heart failure, and vasospastic disorders of the coronary arteries could receive in the United States only a small number of the drugs available to physicians in the rest of the world. In fact, as the 1980's began, there was only one available beta blocking agent released by The Food and Drug Administration; and even as of this writing, no oral calcium antagonist agent. This lag, in part, has been due to the confusion of proper and expeditious methods to define safety and efficacy of such agents so that the United States regulatory agency (Food and Drug Administration) could approve the use of such agents by clinicians. The vast number of new beta blocker and calcium antagonist agents being developed, as well as the long-term use abroad of many new drugs, has raised important questions as to how relative safety and efficacy of such agents can be determined to facilitate availability in the United States.

General

Imprint: Springer
Country of origin: Netherlands
Series: Developments in Cardiovascular Medicine, 18
Release date: November 2011
First published: 1982
Editors: J. Morganroth • E.Neil Moore
Dimensions: 235 x 155 x 21mm (L x W x T)
Format: Paperback
Pages: 419
Edition: Softcover reprint of the original 1st ed. 1982
ISBN-13: 978-9400975637
Categories: Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
LSN: 9400975635
Barcode: 9789400975637

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners